My sister and I were recently
featured in an article in
the Wall Street Journal
on DNA sequencing. Our
family took part in a study
to have our complete DNA
sequenced in the hopes not
only of learning more about
our diseases and our family’s
risk of developing cancer,
but to contribute to
scientists’ understanding
of cancer for future
generations. We haven’t
received our data yet,
but when we do, the first
thing we will do is share it.
Kathy with her twin sister, Karen
Entering a New Era
digitization of health information makes
My sister and I were recently featured
For the first time ever, this kind of
it easier than ever for patients to be a
in an article in the Wall Street Journal
breakthrough science can happen
vital part of the process. In fact, studies
on DNA sequencing. Our family took
rapidly. Why?
like CoMMpass are only possible when
part in a study to have our complete
patients are willing to bank their tissue,
DNA sequenced in the hopes not only
undergo genomic testing, and share
of learning more about our diseases
their health and personal data. Sharing
and our family’s risk of developing
our data — particularly sequencing data,
cancer, but to contribute to scientists’
which provides unprecedented insight
understanding of cancer for future
into the biological underpinnings of
generations. We haven’t received our
health and disease — not only helps us
data yet, but when we do, the first
learn about our disease and improve
thing we will do is share it.
We are at the center of the perfect
convergence of massive technological
leaps. Genome sequencing, for one,
has seen costs plunge from
$3 billion to under $3,000, and time
collapse from a decade to a few days.
Bioinformatics advances now allow
us to collaboratively analyze floods
of sequencing data — and to do so
increasingly in the cloud. And, third, the
our treatment options, but contributes
to knowledge that is vital to the
development of new treatments that
extend lives and lead to cures.
PRE CISI O N M E D I C I N E
5